ziprasidone mesylate
NDC 68083-340, ziprasidone mesylate, injection, powder, lyophilized, for solution, from Gland Pharma Limited.
- Product NDC
- 68083-340
- Status
- Listed
- Labeler
- Gland Pharma Limited
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211908
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68083-340 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZIPRASIDONE MESYLATE20 mg/mL
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68083-340-01 | 68083034001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-340-01) / 1 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/77a10f48-e300-465f-81b5-54be38daa4b3
Use it
Look up 68083-340 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68083-340 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68083-340. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.